Lana Medical Company (TADAWUL:9587)

Lana Medical Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	92.3	84.09	48.63	40.8	31.97
Revenue Growth (YoY)	9.77%	72.89%	19.20%	27.64%	-
Cost of Revenue	71.47	59.19	29.42	21.93	15.1
Gross Profit	20.84	24.9	19.21	18.87	16.87
Selling, General & Admin	18.81	15.3	11.61	9.04	8.47
Operating Expenses	14.89	16.42	19.58	12.35	9.55
Operating Income	5.95	8.48	-0.37	6.52	7.32
Interest Expense	-2.39	-0.48	-0.34	-0.2	-0.08
Earnings From Equity Investments	-0.75	5.37	-	-	-
Other Non Operating Income (Expenses)	0.21	0.25	0.18	0.29	0.54
EBT Excluding Unusual Items	3.02	13.62	-0.52	6.62	7.78
Gain (Loss) on Sale of Assets	0.73	-	-	-	0.01
Pretax Income	3.75	13.62	-0.52	6.62	7.79
Income Tax Expense	1.05	1.16	1.41	1.13	1.2
Net Income	2.7	12.46	-1.93	5.49	6.59
Net Income to Common	2.7	12.46	-1.93	5.49	6.59
Net Income Growth	-78.36%	-	-	-16.70%	-
Shares Outstanding (Basic)	54	54	46	45	33
Shares Outstanding (Diluted)	54	54	46	45	33
Shares Change (YoY)	-	18.38%	1.37%	37.11%	-
EPS (Basic)	0.05	0.23	-0.04	0.12	0.20
EPS (Diluted)	0.05	0.23	-0.04	0.12	0.20
EPS Growth	-78.36%	-	-	-39.25%	-
Free Cash Flow	-10.37	-3.73	-2.43	0.5	-12.17
Free Cash Flow Per Share	-0.19	-0.07	-0.05	0.01	-0.37
Gross Margin	22.57%	29.61%	39.50%	46.25%	52.76%
Operating Margin	6.45%	10.08%	-0.76%	15.99%	22.90%
Profit Margin	2.92%	14.82%	-3.96%	13.46%	20.63%
Free Cash Flow Margin	-11.23%	-4.43%	-5.00%	1.22%	-38.06%
EBITDA	10.27	11.18	1.11	7.54	8.09
EBITDA Margin	11.13%	13.29%	2.29%	18.47%	25.30%
D&A For EBITDA	4.32	2.7	1.48	1.01	0.77
EBIT	5.95	8.48	-0.37	6.52	7.32
EBIT Margin	6.45%	10.08%	-0.76%	15.99%	22.90%
Effective Tax Rate	28.11%	8.51%	-	17.03%	15.36%
Advertising Expenses	0.41	0.35	0.33	0.19	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.